Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.

Muma NA, Singh RK, Vercillo MS, D'Souza DN, Zemaitaitis B, Garcia F, Damjanoska KJ, Zhang Y, Battaglia G, Van de Kar LD.

Neuropharmacology. 2007 Sep;53(4):552-62. Epub 2007 Jul 1.

2.

Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.

Shi J, Damjanoska KJ, Singh RK, Carrasco GA, Garcia F, Grippo AJ, Landry M, Sullivan NR, Battaglia G, Muma NA.

J Pharmacol Exp Ther. 2007 Oct;323(1):248-56. Epub 2007 Jul 23.

PMID:
17646429
3.

Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein.

Shi J, Damjanoska KJ, Zemaitaitis B, Garcia F, Carrasco G, Sullivan NR, She Y, Young KH, Battaglia G, Van De kar LD, Howland DS, Muma NA.

Neuropharmacology. 2006 Sep;51(3):524-35.

PMID:
16769091
4.

Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.

Sullivan NR, Crane JW, Damjanoska KJ, Carrasco GA, D'Souza DN, Garcia F, Van de Kar LD.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):18-26. Epub 2005 Jan 18.

PMID:
15655673
5.

Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats.

Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, Chen Z, Garcia F, Muma NA, Van de Kar LD.

Psychopharmacology (Berl). 2005 Jun;179(4):769-80. Epub 2004 Dec 24.

PMID:
15619113
6.

Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.

D'Souza DN, Zhang Y, Damjanoska KJ, Carrasco GA, Sullivan NR, Garcia F, Battaglia G, Doncarlos LL, Muma NA, Van de Kar LD.

Neuroendocrinology. 2004;80(1):31-41.

PMID:
15385710
7.

Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors.

Carrasco GA, Barker SA, Zhang Y, Damjanoska KJ, Sullivan NR, Garcia F, D'souza DN, Muma NA, van De Kar LD.

Neuroscience. 2004;127(2):261-7.

PMID:
15262317
8.

Short-term cocaine treatment causes neuroadaptive changes in Galphaq and Galpha11 proteins in rats undergoing withdrawal.

Carrasco GA, Damjanoska KJ, D'Souza DN, Zhang Y, Garcia F, Battaglia G, Muma NA, Van de Kar LD.

J Pharmacol Exp Ther. 2004 Oct;311(1):349-55. Epub 2004 Jun 2.

PMID:
15175423
9.

Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.

Zhang Y, Gray TS, D'Souza DN, Carrasco GA, Damjanoska KJ, Dudas B, Garcia F, Zainelli GM, Sullivan Hanley NR, Battaglia G, Muma NA, Van de Kar LD.

J Pharmacol Exp Ther. 2004 Jul;310(1):59-66. Epub 2004 Apr 2.

PMID:
15064330
10.

Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.

Damjanoska KJ, Heidenreich BA, Kindel GH, D'Souza DN, Zhang Y, Garcia F, Battaglia G, Wolf WA, Van de Kar LD, Muma NA.

J Pharmacol Exp Ther. 2004 Jun;309(3):1043-50. Epub 2004 Feb 19.

PMID:
14976228
11.

A region-specific increase in Galphaq and Galpha11 proteins in brains of rats during cocaine withdrawal.

Carrasco GA, Zhang Y, Damjanoska KJ, D'Souza DN, Garcia F, Battaglia G, Muma NA, Van de Kar LD.

J Pharmacol Exp Ther. 2003 Dec;307(3):1012-9. Epub 2003 Oct 8.

PMID:
14534355
12.

Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.

Damjanoska KJ, Van de Kar LD, Kindel GH, Zhang Y, D'Souza DN, Garcia F, Battaglia G, Muma NA.

J Pharmacol Exp Ther. 2003 Aug;306(2):563-71. Epub 2003 Apr 29.

PMID:
12721328
13.

Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD.

J Pharmacol Exp Ther. 2003 Mar;304(3):1209-16.

PMID:
12604698
14.

Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.

Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD.

J Neurosci. 2002 Nov 1;22(21):9635-42.

Supplemental Content

Loading ...
Support Center